Post-approval studies (Phase 4)Study completedNCT02690974
What this trial is testing
Description of Tolerability of LCZ696 (Sacubitril / Valsartan) in Heart Failure With Reduced Ejection Fraction (HFrEF) Treated in Real Life Setting
Who this might be right for
Hearth Failure With Reduced Ejection Fraction (HFrEF)
Novartis Pharmaceuticals 302